Innovation changing the philosophy of glaucoma treatment
Innovation is changing the philosophy of glaucoma treatment from a drop-dependent approach to an interventional, procedure-based approach, according to Savak Teymoorian, MD. “In the pursuit of making glaucoma care better, we ask ourselves, what can we do to improve our patients’ therapy? We realized that eye drop options, as they stand, simply wouldn’t be the… Read More
Dr. John Hovanesian Awarded America’s Best Ophthalmologists 2021
Harvard Eye Associates Awarded on Newsweek’s America’s Best Ophthalmologists 2021 List Laguna Hills, CA – Dr. John A. Hovanesian has been awarded on Newsweek’s list of America’s Best Ophthalmologists 2021. Newsweek and Statista Inc. announced this prestigious award list on July 21st, 2021 and it can currently be viewed on Newsweek’s website. America’s Best Ophthalmologists… Read More
Press Release: Harvard Eye Associates Offers Pioneering New Glaucoma Treatment
The Latest DURYSTA™ Glaucoma Treatment Board-Certified Ophthalmologist, Dr. Savak Teymoorian of Harvard Eye Associates, assisted in the research and development of a new glaucoma drug. Laguna Hills, Ca.—Harvard Eye Associates is able to offer patients dealing with glaucoma a revolutionary new eye treatment that was researched and developed by one of its own board-certified ophthalmologists,… Read More
